Roger D. Bailey Dc Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1119 E College St, Suite 4, Pulaski, TN 38478 Phone: 931-424-3331 Fax: 931-363-9777 |
Zachariah Roberts, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 611 S 1st St, Pulaski, TN 38478 Phone: 931-363-7440 |
Taylormade Medical Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 611 S 1st St, Pulaski, TN 38478 Phone: 931-363-7440 |
Dr. Roger D Bailey, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 1187 W College St, Suite 4, Pulaski, TN 38478 Phone: 931-424-3331 |
Dr. Thomas M Bender, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 611 S 1st St, Pulaski, TN 38478 Phone: 931-363-7440 |
Dr. John Edward Taylor, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 611 S 1st St, Pulaski, TN 38478 Phone: 931-363-7440 |
Dr. Lorraine C Bailey, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 1119 E. College St, Suite 4, Pulaski, TN 38478 Phone: 931-424-3331 Fax: 931-363-9777 |
Dr. Alfred Judson Farrier, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 438 N 1st St, Suite A, Pulaski, TN 38478 Phone: 931-292-6356 |
News Archive
LCZ696, a twice-a-day medicine being investigated for heart failure, acts to enhance the protective neurohormonal systems of the heart (NP system) while simultaneously suppressing the harmful effects of the overactive renin-angiotensin-aldosterone system (RAAS).
A new online tool will help doctors predict which patients are most likely to develop diabetes. The calculator will help doctors identify high risk patients so that they can be tested for the disease and offered lifestyle advice. The test is targeted at people who have been admitted to hospital for emergency care.
A team of researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, has demonstrated sustained regression of advanced melanoma in a study of 17 patients by genetically engineering patients' own white blood cells to recognize and attack cancer cells.
Researchers at the University of Missouri have proven that a compound initially developed as a cholesterol-fighting molecule not only halts the progression of breast cancer, but also can kill the cancerous cells.
Sen. Christopher "Kit" Bond (R-MO) has been recognized for providing important leadership on health care policy issues and working to increase access to vision and eye health care by doctors of optometry from his state and their national organization, the American Optometric Association.
› Verified 6 days ago